MPMarco Pileggi

Marco Pileggi

*This is an algorithmically generated author record based on publicly available information.

Marco Pileggi has a total of 211 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Computed Tomography–Based Imaging Scores in Basilar Artery Occlusions: A Comparison of Predictive Abilities for Functional Outcomes

    by Ronda Lun, Parshva Shah, Lia Carolina Franco, Carlo W. Cereda, Michael Mlynash, Nicole Yuen, Abid Y. Qureshi, Archana Hinduja, Seena Dehkharghani, Adam E. Goldman Yassen, et al.

    BACKGROUND: Posterior circulation large-vessel occlusion strokes have significant morbidity and mortality, but patient selection for acute interventions remains understudied. Multiple computed tomography (CT)–based scores exist, including the CT perfusion–based critical area perfusion score (CAPS), CT angiography–based basilar artery treatment management and posterior circulation CT angiography scores, and CT angiography source image or noncontrast CT–based posterior circulation Alberta Stroke Program Early CT Score, but their predictive values for long-term outcomes after thrombectomy have not been directly compared. METHODS: We conducted a retrospective multicenter cohort study of patients with basilar artery occlusions treated with endovascular thrombectomy. Four CT-based scores were assessed: posterior circulation Alberta Stroke Program Early CT Score, basilar artery treatment management score, posterior circulation CT angiography score, and CAPS. The primary outcome of interest for the study was a favorable functional outcome at 3 months (modified Rankin Scale score, 0–3). We calculated sensitivity, specificity, positive and negative predictive values, and generated receiver operating characteristic curves measuring area under the curve (AUC), which were compared with nonparametric methods. RESULTS: Ninety-eight patients were included for analysis, with an average age of 64.9 ± 15.6 years. The median National Institutes of Health Stroke Scale score was 13.5 (interquartile range, 7.0–23.0). AUC values were highest for the CAPS (AUC, 0.72 [95% CI, 0.63–82]) and lowest for the posterior circulation CT angiography score (AUC, 0.57 [95% CI, 0.45–0.68]; P =0.019). There was a trend toward the CAPS outperforming the basilar artery treatment management score (AUC, 0.66 [95% CI, 0.55–0.77]) and posterior circulation Alberta Stroke Program Early CT Score (AUC, 0.63 [95% CI, 0.52–0.75]) though this was not statistically significant ( P =0.29 and P =0.23, respectively). CAPS ≤3 demonstrated 100% sensitivity and negative predictive value (95% CI, 92.6–100.0%; 95% CI, 75.7–100.0%, respectively) for good outcome but had low specificity (24.0% [95% CI, 14.3–37.4]). CONCLUSIONS: The CT perfusion–based CAPS had the best performance for predicting good functional outcome at 3 months and had high sensitivity and negative predictive values though our finding is limited by the small number of patients who had CAPS >3. The CAPS should be validated in prospective studies.

  • Use of Calibrated Screw Technique (CAST) for complex vertebral compression fractures: retrospective evaluation of clinical outcomes and indications

    by Marco Pileggi, Francesco Adduci, Andrea A Domenighetti, Maurizio Isalberti, Christian Commodaro, Luigi La Barbera, Andrea Cardia, Tomaso Villa, Joshua A Hirsch, Alessandro Cianfoni

    Background: Vertebral compression fractures (VCFs), characterized by middle column involvement, osteonecrotic clefts, split morphology, or pedicle fractures, pose biomechanical challenges that reduce the effectiveness of conventional vertebroplasty and kyphoplasty. We evaluated the feasibility, safety, and clinical outcomes of the Calibrated Screw Technique (CAST), a minimally invasive approach combining percutaneous pedicle screw fixation and targeted cement augmentation, in patients with complex VCFs. Methods: We retrospectively analyzed 147 consecutive patients (155 vertebral levels; mean age 80.1 years), primarily with osteoporotic fractures (80.6%), treated using CAST. Demographic, clinical, and radiographic data were collected at baseline, and at 1 and 6 months. Pain intensity was measured by the numeric rating scale (NRS), and patient perceived outcomes were assessed using patient global impression of change (PGIC). Radiographic outcomes included refracture rates at treated vertebrae, incidence of new fractures, and kyphotic angle correction in mobile fractures. Results: CAST was technically feasible in all cases without major complications. Mean NRS scores improved significantly from 7.7 before the procedure to 3.6 at 1 month and 2.7 at 6 months (P < 0.0001). At the 1 month follow-up, 55.3% of patients reported feeling ‘extremely’ or ‘much improved’ on PGIC, increasing to 69.8% at 6 months. Radiographically, only one asymptomatic refracture occurred at 1 month (0.8%) and none at 6 months. New fracture incidence decreased from 13.8% at 1 month to 4.2% at 6 months. Conclusions: In this study, CAST provided a safe, technically feasible, and durable solution for stabilization and pain relief in complex VCFs unsuitable for conventional augmentation, highlighting its value for challenging VCFs.


  • Open Access

    ErisNet: A Deep Learning Model for Noise Reduction in CT Images

    by Fabio Mattiussi, Francesco Magoga, Andrea Cozzi, Salvatore Ferraro, Gabrio Cadei, Chiara Martini, Svenja Leu, Ebticem Ben Khalifa, Alcide Alessandro Azzena, Marco Pileggi, et al.

    Background: ErisNet, a novel AI model to reduce noise in Computed Tomography images. Methods: We trained ErisNet on 23 post-mortem whole-body CT scans. We assessed the objective performance with mean square error (MSE), peak signal-to-noise ratio (PSNR), structural similarity index (SSIM) measure, visual information fidelity (VIF), edge preservation index (EPI) and noise variance (NV). We assessed the qualitative performance by six radiologists. To support the visual assessment, we placed circular regions of interest (ROI) in the vitreous body, brain, liver and spleen parenchyma and paravertebral muscle. Results: ErisNet achieved MSE 64.07 ± 46.81, PSNR 31.32 ± 3.69 dB, SSIM 0.93 ± 0.06, VIF 0.49 ± 0.09, EPI 0.97 ± 0.01 and NV 64.69 ± 46.80. The ROI analysis showed a reduction in noise: the SD of the HU decreased by 8% in the vitreous body (from 17.6 to 16.2 HU), by 18% in the brain parenchyma (from 18.85 to 15.40 HU) and by 15–19% in the liver, spleen and paravertebral muscle. The six radiologists confirmed these results by assigning high scores (scale from one to five): overall quality 4.5 ± 0.6, noise suppression/detail preservation 4.7 ± 0.5 and diagnostic confidence 4.8 ± 0.4 (p < 0.01). Conclusions: ErisNet improves the quality of CT images and shows strong potential for processing low-dose scans.


  • An Extended Follow-up of Spinal Instrumentation Rescue with Cement Augmentation

    by F. Polinelli, M. Pileggi, I. Cabrilo, C. Commodaro, S.M.J. van Kuijk, A. Cardia, A. Cianfoni

    BACKGROUND AND PURPOSE: Percutaneous cement augmentation has been reported as an effective salvage procedure for frail patients suffering with spinal instrumentation failure, such as screw loosening, hardware breakage, cage subsidence, and fractures within or adjacent to stabilized segments. Favorable results were reported over a median follow-up period of 16 months in a retrospective analysis of 31 consecutive procedures performed in 29 patients. In the present study, the long-term effectiveness of this treatment in avoiding or postponing revision surgery is reported. MATERIALS AND METHODS: Clinical and radiological data of our original cohort of patients were retrospectively collected and reviewed to provide an extended follow-up assessment. The need for revision spinal surgery was assessed as the primary outcome and the radiological stability of the augmented spinal implants was considered as the secondary outcome. RESULTS: An extended radiological follow-up was available in 27/29 patients with an average of 50.9 months. Overall, 18/27 (66.7%) patients, originally candidates for revision surgery, avoided a surgical intervention after a cement augmentation rescue procedure. In the remaining patients, the average interval between the rescue cement augmentation and the revision surgery was 22.5 months. Implant mobilization occurred in 2/27 (7.4%) patients, rod breakage in 1/27 (3.7%), a new fracture within or adjacent to the instrumented segment occurred in 4/27 (14.8%) patients and screw loosening at rescued levels occurred in 5/27 (18.5%) patients. CONCLUSIONS: In this cohort, cement augmentation rescue procedures were found to be effective in avoiding or postponing revision surgery during long-term follow up. ABBREVIATIONS: N/A


  • Open Access

    Effect of General Anesthesia Versus Conscious Sedation/Local Anesthesia on the Outcome of Patients with Minor Stroke and Isolated M2 Occlusion Undergoing Immediate Thrombectomy: A Retrospective Multicenter Matched Analysis

    by Iacopo Valente, Andrea M. Alexandre, Francesca Colò, Valerio Brunetti, Giovanni Frisullo, Arianna Camilli, Anne Falcou, Luca Scarcia, Riccardo Gigli, Irene Scala, et al.


  • Unfavorable clinical outcomes in patients with good collateral scores following endovascular treatment for acute ischemic stroke of the anterior circulation: The UNCLOSE study

    by Arturo Consoli, Marco Pileggi, Atm Hasibul Hasan, Mohammad H Rahman, Alice Venier, Alessandro Sgreccia, Silvia Pizzuto, Oguzhan Coskun, Federico Di Maria, Luca Scarcia, et al.

    Background: Patients with acute ischemic stroke secondary to large vessel occlusions and good collaterals are frequently associated with favorable outcomes after mechanical thrombectomy, although poor outcomes are observed also in this subgroup. We aimed to investigate the factors associated with unfavorable outcomes (modified Rankin Scale3–6) in this specific subgroup of patients. Methods: In total, 219 patients (117 females) with anterior circulation stroke and good collaterals (American Society for Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology grades 3–4), treated by mechanical thrombectomy between 2016 and 2021 at our institution were included in this study. Clinical files and neuroimaging were retrospectively reviewed. Univariate and multivariate analyses were performed to identify the predictors of unfavorable outcomes in the overall population (primary endpoint). Secondary endpoints focused on the analysis of the predictors of unfavorable outcomes in the subgroup of successfully recanalized patients, mortality, and symptomatic intracerebral hemorrhages in the overall population. Results: Poor outcome was observed in 47% of the patients despite the presence of good collaterals. Older age ( p < 0.001), higher baseline National Institute of Health stroke scale ( p < 0.001), no intravenous thrombolysis administration ( p = 0.004), > 3 passes ( p = 0.01), and secondary transfers ( p < 0.001) were associated with the primary endpoint. The multivariate analysis showed a predictive effect of modified treatment in cerebral infarction 2b-3 and of first pass effect on symptomatic intracerebral hemorrhage. Conclusions: Despite good collaterals, defined through the American Society for Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology scale, poor outcomes occurred in almost half of the patients. Patients with good collaterals not receiving intravenous thrombolysis were significantly associated with unfavorable outcomes, whereas first pass effect was not significantly correlated with clinical outcome in this specific cohort of patients. Different methods to assess collaterals should also be investigated.


  • Dural Branches of the Vertebral Artery

    by F. Di Caterino, M. Pileggi

  • Early neurological deterioration in patients with minor stroke due to isolated M2 occlusion undergoing medical management: a retrospective multicenter study

    by Aldobrando Broccolini, Valerio Brunetti, Francesca Colò, Andrea M Alexandre, Iacopo Valente, Anne Falcou, Giovanni Frisullo, Alessandro Pedicelli, Luca Scarcia, Irene Scala, et al.

    Background Patients with minor stroke and M2 occlusion undergoing best medical management (BMM) may face early neurological deterioration (END) that can lead to poor long-term outcome. In case of END, rescue mechanical thrombectomy (rMT) seems beneficial. Our study aimed to define factors relevant to clinical outcome in patients undergoing BMM with the possibility of rMT on END, and find predictors of END. Methods Patients with M2 occlusion and a baseline National Institutes of Health Stroke Scale (NIHSS) score≤5 that received either BMM only or rMT on END after BMM were extracted from the databases of 16 comprehensive stroke centers. Clinical outcome measures were a 90-day modified Rankin Scale (mRS) score of 0–1 or 0–2, and occurrence of END. Results Among 10 169 consecutive patients with large vessel occlusion admitted between 2016 and 2021, 208 patients were available for analysis. END was reported in 87 patients that were therefore all subjected to rMT. In a logistic regression model, END (OR 3.386, 95% CI 1.428 to 8.032), baseline NIHSS score (OR 1.362, 95% CI 1.004 to 1.848) and a pre-event mRS score=1 (OR 3.226, 95% CI 1.229 to 8.465) were associated with unfavorable outcome. In patients with END, successful rMT was associated with favorable outcome (OR 4.549, 95% CI 1.098 to 18.851). Among baseline clinical and neuroradiological features, presence of atrial fibrillation was a predictor of END (OR 3.547, 95% CI 1.014 to 12.406). Conclusion Patients with minor stroke due to M2 occlusion and atrial fibrillation should be closely monitored for possible worsening during BMM and, in this case, promptly considered for rMT.


  • Open Access

    Mechanical Thrombectomy Versus Best Medical Treatment in the Late Time Window in Non-DEFUSE-Non-DAWN Patients: A Multicenter Cohort Study

    by Tolga D. Dittrich, Peter B. Sporns, Lilian F. Kriemler, Salome Rudin, Anh Nguyen, Annaelle Zietz, Alexandros A. Polymeris, Christopher Tränka, Sebastian Thilemann, Benjamin Wagner, et al.

    Background: We assessed the efficacy and safety of mechanical thrombectomy (MT) in adult stroke patients with anterior circulation large vessel occlusion presenting in the late time window not fulfilling the DEFUSE-3 (Thrombectomy for Stroke at 6 to 16 Hours With Selection by Perfusion Imaging trial) and DAWN (Thrombectomy 6 to 24 Hours After Stroke With a Mismatch Between Deficit and Infarct trial) inclusion criteria. Methods: Cohort study of adults with anterior circulation large vessel occlusion admitted between 6 and 24 hours after last-seen-well at 5 participating Swiss stroke centers between 2014 and 2021. Mismatch was assessed by computer tomography or magnetic resonance imaging perfusion with automated software (RAPID or OLEA). We excluded patients meeting DEFUSE-3 and DAWN inclusion criteria and compared those who underwent MT with those receiving best medical treatment alone by inverse probability of treatment weighting using the propensity score. The primary efficacy end point was a favorable functional outcome at 90 days, defined as a modified Rankin Scale score shift toward lower categories. The primary safety end point was symptomatic intracranial hemorrhage within 7 days of stroke onset; the secondary was all-cause mortality within 90 days. Results: Among 278 patients with anterior circulation large vessel occlusion presenting in the late time window, 190 (68%) did not meet the DEFUSE-3 and DAWN inclusion criteria and thus were included in the analyses. Of those, 102 (54%) received MT. In the inverse probability of treatment weighting analysis, patients in the MT group had higher odds of favorable outcomes compared with the best medical treatment alone group (modified Rankin Scale shift: acOR, 1.46 [1.02–2.10]; P =0.04) and lower odds of all-cause mortality within 90 days (aOR, 0.59 [0.37–0.93]; P =0.02). There were no significant differences in symptomatic intracranial hemorrhage (MT versus best medical treatment alone: 5% versus 2%, P =0.63). Conclusions: Two out of 3 patients with anterior circulation large vessel occlusion presenting in the late time window did not meet the DEFUSE-3 and DAWN inclusion criteria. In these patients, MT was associated with higher odds of favorable functional outcomes without increased rates of symptomatic intracranial hemorrhage. These findings support the enrollment of patients into ongoing randomized trials on MT in the late window with more permissive inclusion criteria.